{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:28:17Z","timestamp":1790803697117,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In the recent years, the overall trends in hospital admission and mortality of interstitial lung disease (ILD) are unknown. In addition, there was some evidence that interstitial lung disease death rate highest in the winter but this finding was only available in one study. This study will investigate the trend and seasonal variations in hospital admission and mortality rates of ILD from 2006 to 2016.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>From the Nationwide Inpatient Sample database, we collected all cases with the International Classification of Diseases (ICD)-9 or ICD-10 codes of ILD excluding identifiable external causes (drug, organic or inorganic dusts) from 2006 to 2016. Hospitalization rates of each year were calculated based on U.S Census population data. Monthly hospitalization and in-hospital mortality rates were analyzed by seasonal and trend decomposition. Subgroups of idiopathic interstitial fibrosis (IPF), acute respiratory failure (ARF), pneumonia were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 2006 to 2016, all-cause hospital admission rate of patients with interstitial lung disease (ILD) and IPF-only subgroup declined but their overall mortality remained unchanged (except IPF subgroup and acute respiratory failure subgroup). Acute respiratory failure related admission account for 23% of all causes and pneumonia 17.6%. Mortality of ILD in general and subgroup of ILD with ARF was highest in winter, up to 8.13%\u2009\u00b1\u20090.60 and 26.3%\u2009\u00b1\u200910.2% respectively. The seasonal variations of hospital admission and mortality of ILD in general was not changed when infectious pneumonia cases were ruled out. All cause admission rates were highest in months from January to April. Subgroup analysis also showed seasonal variations with highest hospitalization rates for all subgroups (IPF, ARF, pneumonia) in the months from December to April (winter to early Spring).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>From 2006 to 2016, admission rates of ILD of all causes and IPF subgroup declined but in-hospital mortality of ILD of all causes remained unchanged. Mortality of IPF subgroup and acute respiratory failure subgroup trended down. All-cause hospital admissions and mortality of ILD have a strong seasonal variation. Hospitalization rates for all subgroups (IPF, ARF, pneumonia) were highest in the months from December to April.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-020-01421-0","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T09:03:45Z","timestamp":1592298225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Trends and seasonal variation of hospitalization and mortality of interstitial lung disease in the United States from 2006 to 2016"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3155-7568","authenticated-orcid":false,"given":"An Thi Nhat","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Shmelev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Charbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"issue":"Suppl 5","key":"1421_CR1","first-page":"v1","volume":"63","author":"B Bradley","year":"2008","unstructured":"Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, Hirani N, Hubbard R, Lake F, Millar AB, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and new Zealand and the Irish thoracic society. Thorax. 2008;63(Suppl 5):v1\u201358.","journal-title":"Thorax"},{"key":"1421_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2213-0802-2-4","volume":"2","author":"KC Meyer","year":"2014","unstructured":"Meyer KC. Diagnosis and management of interstitial lung disease. Transl Respir Med. 2014;2:4.","journal-title":"Transl Respir Med"},{"key":"1421_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","year":"2002","unstructured":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS executive committee, June 2001. Am J Respir Crit Care Med. 2002;165:277\u2013304.","journal-title":"Am J Respir Crit Care Med"},{"key":"1421_CR4","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1513\/AnnalsATS.201404-145OC","volume":"11","author":"JP Hutchinson","year":"2014","unstructured":"Hutchinson JP, McKeever TM, Fogarty AW, Navaratnam V, Hubbard RB. Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century. Ann Am Thorac Soc. 2014;11:1176\u201385.","journal-title":"Ann Am Thorac Soc"},{"key":"1421_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/CLEP.S54815","volume":"5","author":"B Ley","year":"2013","unstructured":"Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol. 2013;5:483\u201392.","journal-title":"Clin Epidemiol"},{"key":"1421_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"1421_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3402\/ijch.v66i2.18237","volume":"66","author":"HO Koskela","year":"2007","unstructured":"Koskela HO. Cold air-provoked respiratory symptoms: the mechanisms and management. Int J Circumpolar Health. 2007;66:91\u2013100.","journal-title":"Int J Circumpolar Health"},{"key":"1421_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13601-018-0208-9","volume":"8","author":"M D'Amato","year":"2018","unstructured":"D'Amato M, Molino A, Calabrese G, Cecchi L, Annesi-Maesano I, D'Amato G. The impact of cold on the respiratory tract and its consequences to respiratory health. Clin Transl Allergy. 2018;8:20.","journal-title":"Clin Transl Allergy"},{"key":"1421_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/15412555.2015.1089846","volume":"13","author":"NN Hansel","year":"2016","unstructured":"Hansel NN, McCormack MC, Kim V. The effects of air pollution and temperature on COPD. COPD. 2016;13:372\u20139.","journal-title":"COPD"},{"key":"1421_CR10","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.2147\/COPD.S174148","volume":"13","author":"C Hoffmann","year":"2018","unstructured":"Hoffmann C, Hanisch M, Heinsohn JB, Dostal V, Jehn M, Liebers U, Pankow W, Donaldson GC, Witt C. Increased vulnerability of COPD patient groups to urban climate in view of global warming. Int J Chron Obstruct Pulmon Dis. 2018;13:3493\u2013501.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1421_CR11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1513\/AnnalsATS.201801-070OC","volume":"15","author":"JY So","year":"2018","unstructured":"So JY, Zhao H, Voelker H, Reed RM, Sin D, Marchetti N, Criner GJ. Seasonal and regional variations in chronic obstructive pulmonary disease exacerbation rates in adults without cardiovascular risk factors. Ann Am Thorac Soc. 2018;15:1296\u2013303.","journal-title":"Ann Am Thorac Soc"},{"key":"1421_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1378\/chest.08-0703","volume":"136","author":"AL Olson","year":"2009","unstructured":"Olson AL, Swigris JJ, Raghu G, Brown KK. Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter. Chest. 2009;136:16\u201322.","journal-title":"Chest"},{"key":"1421_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1152\/jappl.1990.69.1.362","volume":"69","author":"E Daviskas","year":"1990","unstructured":"Daviskas E, Gonda I, Anderson SD. Mathematical modeling of heat and water transport in human respiratory tract. J Appl Physiol. 1990;69:362\u201372.","journal-title":"J Appl Physiol"},{"key":"1421_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1574-695X.1999.tb01389.x","volume":"26","author":"JM Hament","year":"1999","unstructured":"Hament JM, Kimpen JL, Fleer A, Wolfs TF. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol. 1999;26:189\u201395.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"Suppl 6","key":"1421_CR15","first-page":"S737","volume":"6","author":"JW Tang","year":"2009","unstructured":"Tang JW. The effect of environmental parameters on the survival of airborne infectious agents. J R Soc Interface. 2009;6(Suppl 6):S737\u201346.","journal-title":"J R Soc Interface"},{"issue":"Suppl 6A","key":"1421_CR16","doi-asserted-by":"publisher","first-page":"4S","DOI":"10.1016\/S0002-9343(01)01058-0","volume":"112","author":"AS Monto","year":"2002","unstructured":"Monto AS. Epidemiology of viral respiratory infections. Am J Med. 2002;112(Suppl 6A):4S\u201312S.","journal-title":"Am J Med"},{"key":"1421_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1183\/09031936.00176307","volume":"32","author":"CE Daniels","year":"2008","unstructured":"Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J. 2008;32:170\u20134.","journal-title":"Eur Respir J"},{"key":"1421_CR18","doi-asserted-by":"publisher","first-page":"963","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00005","volume":"142","author":"FJ Martinez","year":"2005","unstructured":"Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, Noble PW, Raghu G, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med. 2005;142:963\u20137.","journal-title":"Ann Intern Med"},{"key":"1421_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","volume":"176","author":"HR Collard","year":"2007","unstructured":"Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176:636\u201343.","journal-title":"Am J Respir Crit Care Med"},{"key":"1421_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.chest.2015.12.026","volume":"149","author":"T Moua","year":"2016","unstructured":"Moua T, Westerly BD, Dulohery MM, Daniels CE, Ryu JH, Lim KG. Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis. Chest. 2016;149:1205\u201314.","journal-title":"Chest"},{"key":"1421_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12890-018-0642-4","volume":"18","author":"M Karkkainen","year":"2018","unstructured":"Karkkainen M, Nurmi H, Kettunen HP, Selander T, Purokivi M, Kaarteenaho R. Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis. BMC Pulm Med. 2018;18:69.","journal-title":"BMC Pulm Med"},{"key":"1421_CR22","doi-asserted-by":"publisher","first-page":"e113500","DOI":"10.1371\/journal.pone.0113500","volume":"9","author":"H Marti-Soler","year":"2014","unstructured":"Marti-Soler H, Gonseth S, Gubelmann C, Stringhini S, Bovet P, Chen PC, Wojtyniak B, Paccaud F, Tsai DH, Zdrojewski T, Marques-Vidal P. Seasonal variation of overall and cardiovascular mortality: a study in 19 countries from different geographic locations. PLoS One. 2014;9:e113500.","journal-title":"PLoS One"},{"key":"1421_CR23","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/archinte.163.10.1180","volume":"163","author":"SP Patil","year":"2003","unstructured":"Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003;163:1180\u20136.","journal-title":"Arch Intern Med"},{"key":"1421_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000441687","volume":"168","author":"BP Kaur","year":"2015","unstructured":"Kaur BP, Lahewala S, Arora S, Agnihotri K, Panaich SS, Secord E, Levine D. Asthma: hospitalization trends and predictors of in-hospital mortality and hospitalization costs in the USA (2001-2010). Int Arch Allergy Immunol. 2015;168:71\u20138.","journal-title":"Int Arch Allergy Immunol"},{"key":"1421_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2147\/COPD.S148393","volume":"13","author":"RA Wise","year":"2018","unstructured":"Wise RA, Calverley PM, Carter K, Clerisme-Beaty E, Metzdorf N, Anzueto A. Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR((R)) trial. Int J Chron Obstruct Pulmon Dis. 2018;13:605\u201316.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1421_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1465-9921-13-3","volume":"13","author":"M Chilosi","year":"2012","unstructured":"Chilosi M, Poletti V, Rossi A. The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res. 2012;13:3.","journal-title":"Respir Res"},{"key":"1421_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1378\/chest.13-2424","volume":"147","author":"AW Brown","year":"2015","unstructured":"Brown AW, Fischer CP, Shlobin OA, Buhr RG, Ahmad S, Weir NA, Nathan SD. Outcomes after hospitalization in idiopathic pulmonary fibrosis: a cohort study. Chest. 2015;147:173\u20139.","journal-title":"Chest"},{"key":"1421_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1472-6963-8-160","volume":"8","author":"R Moineddin","year":"2008","unstructured":"Moineddin R, Nie JX, Domb G, Leong AM, Upshur RE. Seasonality of primary care utilization for respiratory diseases in Ontario: a time-series analysis. BMC Health Serv Res. 2008;8:160.","journal-title":"BMC Health Serv Res"},{"key":"1421_CR29","first-page":"173","volume":"9","author":"S Mori","year":"2015","unstructured":"Mori S, Furukawa H, Kawaguchi Y, Suda T, Tasaka S. Current developments in interstitial lung disease. Clin Med Insights Circ Respir Pulm Med. 2015;9:173\u20137.","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"1421_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1146\/annurev-med-022613-090415","volume":"65","author":"S Kripalani","year":"2014","unstructured":"Kripalani S, Theobald CN, Anctil B, Vasilevskis EE. Reducing hospital readmission rates: current strategies and future directions. Annu Rev Med. 2014;65:471\u201385.","journal-title":"Annu Rev Med"},{"key":"1421_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1164\/rccm.201902-0456OC","volume":"200","author":"TM Dempsey","year":"2019","unstructured":"Dempsey TM, Sangaralingham LR, Yao X, Sanghavi D, Shah ND, Limper AH. Clinical effectiveness of Antifibrotic medications for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200:168\u201374.","journal-title":"Am J Respir Crit Care Med"},{"key":"1421_CR32","doi-asserted-by":"publisher","first-page":"S1740","DOI":"10.21037\/jtd.2019.04.62","volume":"11","author":"S Saito","year":"2019","unstructured":"Saito S, Alkhatib A, Kolls JK, Kondoh Y, Lasky JA. Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF). J Thorac Dis. 2019;11:S1740\u201354.","journal-title":"J Thorac Dis"},{"key":"1421_CR33","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1513\/AnnalsATS.201610-764OC","volume":"14","author":"B Ley","year":"2017","unstructured":"Ley B, Urbania T, Husson G, Vittinghoff E, Brush DR, Eisner MD, Iribarren C, Collard HR. Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case validation and improvement. Ann Am Thorac Soc. 2017;14:880\u20137.","journal-title":"Ann Am Thorac Soc"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01421-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-020-01421-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01421-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T19:15:10Z","timestamp":1623784510000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-01421-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1421"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-01421-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-18341\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-18341\/v1","asserted-by":"object"}]},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"18 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is a study based on large national administrative database that is available for public. Consent and ethics approval was waived and not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest and no financial support to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}